Related Experiment Video
Updated: Aug 12, 2026

13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Immunochemical study in two cases of alpha chain disease
Summary
This study describes the first two cases of alpha-chain deposition disease (alpha-CD) in the USSR. Researchers identified alpha-chain proteins in patient secretions and confirmed diagnostic methods for alpha-CD.
Area of Science:
- Immunology
- Protein chemistry
Background:
- Alpha-chain deposition disease (alpha-CD) is a rare disorder characterized by the deposition of immunoglobulin alpha-chains.
- Understanding the immunochemical characteristics and diagnostic markers of alpha-CD is crucial for patient management.
Observation:
- The study details the first two recognized cases of alpha-CD in the USSR.
- Immunochemical analysis revealed typical patterns consistent with alpha-CD.
- Alpha-chain proteins were detected in patient sera using specific antisera against IgA and its components.
Findings:
- Both immunoelectrophoresis (IEP) and single radial immunodiffusion (SRID) proved effective for alpha-CD detection, with SRID showing distinct double rings.
- Alpha-chain proteins were present in various secretions, including coprofiltrates, saliva, and urine.
- In coprofiltrates, alpha-chain proteins were bound to the secretory component (SC), while in urine and saliva, free alpha-chain proteins were observed.
- Polymeric (dimeric) forms of alpha-chain proteins were confirmed only in coprofiltrates, not in urine or saliva.
- One patient exhibited a significant shift in the kappa/lambda ratio towards kappa chains in serum and IgG fractions.
Implications:
- The findings highlight the utility of specific immunochemical techniques for diagnosing alpha-CD.
- The differential binding of secretory component in various secretions provides insights into the disease's pathophysiology.
- The observed kappa/lambda ratio shift may indicate an altered immune response or an early stage of monoclonal gammopathy.
More Related Videos
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016